Does IGF-1 play a role in the etiopathogenesis of non-functioning adrenocortical adenoma?
- 49 Downloads
The aim of this study was to investigate the possible association of insulin-like growth factor-1 (IGF-1) with the pathogenesis of non-functioning adrenocortical adenomas (NFAs).
This study included 50 female patients (mean age 54 years) with NFAs, 55 patients (mean age 48 years; 20 male, 35 female) with acromegaly and 38 female control subjects (mean age 58 years). Body mass index (BMI) and waist circumference (WC) of the subjects were recorded and blood samples for IGF-1 were taken. Insulin resistance was calculated using the homeostatic model assessment (HOMA) score. Since most of the acromegaly patients had been using medicine that could have effected insulin resistance, HOMA scores were calculated only in patients with NFAs and the controls. Computerized tomography or magnetic resonance imaging was taken of the acromegalics and controls to detect adrenal mass frequency.
The mean age was similar among the groups. As expected, the serum IGF-1 levels were significantly higher in patients with acromegaly than in patients with NFAs and the controls (p < 0.001). Although BMI, WC, and serum IGF-1 levels were significantly higher (p < 0.001) in patients with NFAs, the HOMA scores were similar between patients with NFAs and control groups. Although none of the control subjects had adrenal masses, NFAs were detected in 14 (25%) out of 55 acromegalic patients.
Higher serum IGF-1 levels in patients with NFAs compared to the control group and an increased prevalence of NFAs in acromegaly patients compared to control subjects and the general population suggest an association of IGF-1 with the etiopathogenesis of NFA.
KeywordsAdrenal incidentaloma Non-functioning adrenocortical adenoma IGF-1 Insulin resistance
We would like to thank Prof. Dr. Ramis Colak and Prof. Dr. Ayşegul Atmaca for contributing their patients to this study, and we are also grateful to Prof. Dr. Murat Danaci and Prof. Dr. Mehmet Selim Nural for the radiologic evaluation of the subjects included in this study.
The present study was supported by Ondokuz Mayis University Scientific Research Funding (Project Code No: 1904.12.022).
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
The investigation was conducted according to the principles expressed in the Declaration of Helsinki.
The participants signed informed consent.
- 3.Bovio S, Cataldi A, Reimondo G, Sperone P, Novello S, Berruti A, Borasio P, Fava C, Dogliotti L, Scagliotti GV, Angeli A, Terzolo M (2006) Prevalence of adrenal incidentaloma in a contemporary computerized tomography series. J Endocrinol Invest 29:298–302. https://doi.org/10.1007/BF03344099 CrossRefPubMedGoogle Scholar
- 4.Peppa M, Boutati E, Koliaki C, Papaefstathiou N, Garoflos E, Economopoulos T, Hadjidakis D, Raptis SA (2010) Insulin resistance and metabolic syndrome in patients with non-functioning adrenal incidentalomas: a cause-effect relationship? Metabolism 59:1435–1441. https://doi.org/10.1530/EJE-10-0246 CrossRefPubMedGoogle Scholar
- 9.Rechler MM, Zapf J, Nissley SP, Froesch ER, Moses AC, Podskalny JM, Schilling EE, Humbel RE (1980) Interaction of insulin-like growth factors I and II and multiplication stimulating activity with receptors and serum protein carriers. Endocrinology 107:1451–1459. https://doi.org/10.1210/endo-107-5-1451 CrossRefPubMedGoogle Scholar
- 13.Chiodini I, Adda G, Scillitani A, Coletti F, Morelli V, Di Lembo S, Epaminonda P, Masserini B, Beck-Peccoz P, Orsi E, Ambrosi B, Arosio M (2007) Cortisol secretion in patients with type 2 diabetes: relationship with chronic complications. Diabetes Care 30:83–88. https://doi.org/10.2337/dc06-1267 CrossRefPubMedGoogle Scholar
- 16.Scaroni C, Selice R, Benedini S, De Menis E, Arosio M, Ronchi C, Gasperi M, Manetti L, Arnaldi G, Polenta B, Boscaro M, Albiger N, Martino E, Mantero F (2008) Adrenal morpho-functional alterations in patients with acromegaly. J Endocrinol Invest 31:602–606. https://doi.org/10.1007/BF03345609 CrossRefPubMedGoogle Scholar
- 18.Ceccato F, Occhi G, Albiger NM, Rizzati S, Ferasin S, Trivellin G, Mantero F, Scaroni C (2011) Adrenal lesions in acromegaly: do metabolic aspects and aryl hydrocarbon receptor interacting protein gene have a role? Evaluation at baseline and after long-term follow-up. J Endocrinol Invest 34:353–360. https://doi.org/10.1007/BF03347459 CrossRefPubMedGoogle Scholar
- 19.Fassnacht M, Arlt W, Bancos I, Dralle H, Newell-Price J, Tabarin A, Terzolo M, Tsagarakis S, Dekkers OM (2016) Management of adrenal incidentalomas: European society of endocrinology clinical practice guideline in collaboration with the European network for the study of adrenal tumors. Eur J Endocrinol 175:G1–G34. https://doi.org/10.1530/EJE-16-0467 CrossRefPubMedGoogle Scholar
- 22.Terzolo M, Reimondo G, Gasperi M, Cozzi R, Pivonello R, Vitale G, Scillitani A, Attanasio R, Cecconi E, Daffara F, Gaia E, Martino E, Lombardi G, Angeli A, Colao A (2005) Colonoscopic screening and follow-up in patients with acromegaly: a multicenter study in Italy. J Clin Endocrinol Metab 90:84–90. https://doi.org/10.1210/jc.2004-0240 CrossRefPubMedGoogle Scholar
- 32.Tsagarakis S, Kokkoris P, Roboti C, Malagari C, Kaskarelis J, Vlassopoulou V, Alevizaki C, Thalassinos N (1998) The low-dose dexamethasone suppression test in patients with adrenal incidentalomas: comparisons with clinically euadrenal subjects and patients with Cushing’s syndrome. Clin Endocrinol (Oxf) 48:627–633CrossRefGoogle Scholar
- 34.Perogamvros I, Vassiliadi DA, Karapanou O, Botoula E, Tzanela M, Tsagarakis S (2015) Biochemical and clinical benefits of unilateral adrenalectomy in patients with subclinical hypercortisolism and bilateral adrenal incidentalomas. Eur J Endocrinol 173:719–725. https://doi.org/10.1530/eje-15-0566 CrossRefPubMedGoogle Scholar
- 35.Muscogiuri G, Sorice GP, Prioletta A, Mezza T, Cipolla C, Salomone E, Giaccari A, Pontecorvi A, Della Casa S (2011) The size of adrenal incidentalomas correlates with insulin resistance. Is there a cause-effect relationship? Clin Endocrinol (Oxf) 74(3):300–305. https://doi.org/10.1111/j.1365-2265.2010.03928.x CrossRefGoogle Scholar
- 39.Schneider HJ, Saller B, Klotsche J, März W, Erwa W, Wittchen HU, Stalla GK (2006) Opposite associations of age-dependent insulin-like growth factor-I standard deviation scores with nutritional state in normal weight and obese subjects. Eur J Endocrinol 154:699–706. https://doi.org/10.1530/eje.1.02131 CrossRefPubMedGoogle Scholar